DDrare: Database of Drug Development for Rare Diseases

Lutein (DrugBank: Lutein)

2 diseases

ID	Disease name (Link within this page)	Number of trials
90	Retinitis pigmentosa	2
164	Oculocutaneous albinism	1

90. Retinitis pigmentosa [ 103 clinical trials, 158 drugs, (DrugBank: 42 drugs), 52 drug target genes, 107 drug target pathways]

Searched query = "Retinitis pigmentosa", "Rod dystrophy", "Rod-Cone Dystrophy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

2 / 103 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00346333 (ClinicalTrials.gov)	July 2003	27/6/2006	Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A	Randomized Clinical Trial for Retinitis Pigmentosa	Retinitis Pigmentosa	Drug: Lutein;Dietary Supplement: Cornstarch control	National Eye Institute (NEI)	NULL	Completed	18 Years	60 Years	All	240	Phase 3	United States
2	NCT00029289 (ClinicalTrials.gov)	April 2001	9/1/2002	Effects of Lutein in Retinitis Pigmentosa	Effects of Lutein in Retinitis Pigmentosa	Retinitis Pigmentosa	Drug: Lutein (10 or 30 mg/day) capsules	National Center for Complementary and Integrative Health (NCCIH)	NULL	Completed					Phase 1;Phase 2	United States

164. Oculocutaneous albinism [ 15 clinical trials, 57 drugs, (DrugBank: 34 drugs), 34 drug target genes, 136 drug target pathways]

Searched query = "Oculocutaneous albinism", "Hermansky-Pudlak syndrome", "Chediak-Higashi syndrome", "Griscelli syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 15 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02200263 (ClinicalTrials.gov)	November 2014	23/7/2014	The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism	A Randomized Placebo-controlled Trial to Investigate the Effect of Lutein and Zeaxanthin Supplementation on Macular Pigment and Visual Function in Albinism - LUtein for VIsion in Albinism (LUVIA)	Ocular Albinism (OA);Oculocutaneous Albinism (OCA)	Dietary Supplement: Lutein plus Zeaxanthin;Dietary Supplement: Placebo	Johns Hopkins University	Clark Charitable Foundation Inc.	Completed	12 Years	N/A	All	10	N/A	United States